JBT Marel Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

Full Year Revenue: $3.8 billion, exceeding guidance.

Adjusted EBITDA: $600 million, margin of 15.8%.

Adjusted EPS: $6.41, an increase from $6.15 in 2024.

Leverage Ratio: Improved to less than 2.9x, down from just below 4x at the transaction's completion.

Fourth Quarter Revenue: Over $1 billion, contributing to strong year-end performance.

2Strategic Updates and Business Highlights

Successful integration of JBT and Marel, achieving significant synergy savings and order synergies of $30 million for the year, with over half realized in Q4.

Strong demand in protein markets, particularly poultry, which rebounded after two years of underinvestment.

Enhanced customer value proposition through integrated solutions across product lines, leading to improved order capture and market positioning.

Positive reception at the IPPE expo showcasing JBT Marel’s integrated solutions.

3Forward Guidance and Outlook

2026 Revenue Growth: Expected between 5% to 7%, with adjusted EBITDA margins projected at 17% to 17.5%.

Adjusted EPS Guidance: Forecasted between $8.00 to $8.50, reflecting a 29% increase at the midpoint.

Anticipated continued strength in poultry demand and recovery in prepared foods.

Q1 2026 revenue forecasted at $920 million to $940 million, with an adjusted EBITDA margin of 14% to 15%.

4Bad News, Challenges, or Points of Concern

Tariff Impact: Higher tariffs have negatively affected margins, with an estimated $43 million cost for 2025 and ongoing tariff costs expected to impact 2026 margins by 25 to 50 basis points.

Operational Inefficiencies: Challenges in the Prepared Food & Beverage segment, particularly related to AGV, are expected to persist into early 2026.

Market Volatility: The evolving tariff landscape poses risks to cost structures and pricing strategies.

5Notable Q&A Insights

Order Dynamics: Poultry remains the strongest market, with expectations of continued investment in both poultry and prepared foods.

Synergy Expectations: The company is ahead of its original target for cumulative revenue synergies, with further updates expected at the upcoming Investor Day.

R&D and SG&A: Future disclosures will separate R&D and SG&A expenses, with a focus on harmonizing accounting practices between legacy businesses.

Capital Allocation: Plans to maintain a leverage ratio of 2 to 2.5x before considering further capital allocation strategies, including potential M&A opportunities. Overall, JBT Marel demonstrated strong financial performance in 2025, with a positive outlook for 2026, despite facing challenges related to tariffs and operational inefficiencies in certain segments.